ETROLIZUMAB VERSUS INFLIXIMAB FOR TREATING PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 GARDENIA STUDY

Silvio Danese  1     Jean-Frederic Colombel  2     Milan Lukas  3     Javier Gisbert  4     Geert R. D'Haens  5     Bu Hayee  6     Remo Pannacione  7     Hyun-Soo Kim     Walter Reinisch     Helen Tyrrell     Young Oh     Swati Tole     Akiko Chai     Kirsten Chamberlain-James     Meina Tao Tang     Stefan Schreiber    
1 Humanitas University,Milan,Italy
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 Charles University,Prague,Czech Republic
4 La Princesa University Hospital, IIS-IP and CIBEREHED,Madrid,Spain
5 Amsterdam University Medical Center,Amsterdam,Netherlands
6 Kings College London,London,United Kingdom
7 University of Calgary,Ca

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing